First Word

COVID-19 UPDATE: Ringworm med is a silver bullet? 2021-2023 EBIT margins likely surpass Street. Adding +19 epicenter stocks. See note

Click HERE to access the FSInsight COVID-19 Daily Chartbook.


__________________________________________

Our 2021 Year Ahead Outlook will be released Thursday, December 17th at 3:00 PM EST

Joining us for a webinar, which will include the Fundstrat Macro Team.  The following topics will be discussed:   

• Overall macro and strategy outlook 2021
• Economic outlook, what can we reasonably expect for GDP growth?
• Where are we in this investment cycle and what themes will dominate?
• We discuss key policy risks and upsides 
• New investment themes
• Full EPS and sector outlook
   
Don't miss it!!!!

You must register in advance. 
Register here to attend --> REGISTRATION LINK

Should you have any questions, please do not hesitate to contact us at (212) 293-7140 or email inquiry@fsinsight.com

__________________________________________



STRATEGY: Epicenter 2021-2023 EBIT margins likely massively beat Street consensusThe absolute number of COVID-19 cases continues to set new records and Thursday was 213,446, but the 7D delta (leading indicator) is slowing and ex-CA (which has ~30,000 per day), this 7D delta is now negative.  This is a confirmed rollover.- but it is 'tentative' because post-Thanksgiving, cases can again surg...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Want to receive Regular Market Updates to your Inbox?

I am your default error :)